前收市價 | 1.7900 |
開市 | 1.7700 |
買盤 | 1.7700 x 100 |
賣出價 | 1.8800 x 200 |
今日波幅 | 1.7000 - 1.8800 |
52 週波幅 | 1.5900 - 16.8000 |
成交量 | |
平均成交量 | 234,700 |
市值 | 4.118M |
Beta 值 (5 年,每月) | 1.04 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -2.2000 |
業績公佈日 | 2024年5月08日 - 2024年5月13日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 37.50 |
Now could be a great time for investors to consider stacking up on penny stocks. These companies often have significant growth potential. But they trade at low prices, typically under $5 per share. Penny stocks tend to be highly volatile, with the potential for rapid gains or losses. This requires careful research and risk management. Fortunately, some of the better-known penny stocks are covered by Wall Street analysts who give strong buy ratings. This is a positive indicator, as analysts close
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q4 2023 Earnings Call Transcript March 5, 2024 TRACON Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.01, expectations were $-0.03. TCON isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day ladies and gentlemen and […]
It’s time to start Tuesday trading with a breakdown of the biggest pre-market stock movers worth watching this morning! Moving stocks this morning are collaboration agreements, merger plans, earnings, public share offerings and more. Let’s get into that news down below!InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biggest Pre-Market Stock Movers: 10 Top Gainers Tracon Pharmaceuticals (NASDAQ:TCON) stock is rocketing more than 54% with heavy trading after announcing a product dev